Focused oncology audience
Reach readers working in cancer biology, translational medicine, clinical care, and computational oncology.
About the journal
Overview
iCancer is a newly established open-access journal launched by Apex Science Publication for high-quality cancer research across biomedical discovery, clinical oncology, artificial intelligence, and precision medicine.
Journal Scope
The journal publishes original research, methods, reviews, and perspectives that promote the intersection of cancer biology, clinical medicine, biomedical data science, and patient-centered care.
- Basic and translational cancer research, including mechanisms, biomarkers, tumor microenvironment, immunology, metastasis, and therapeutic resistance.
- Clinical oncology, including diagnosis, systemic treatment, surgery, radiotherapy, clinical trials, supportive care, survivorship, and quality of life.
- Precision oncology, including multi-omics, molecular pathology, liquid biopsy, imaging, digital pathology, and decision-support tools.
- Artificial intelligence, real-world evidence, cancer epidemiology, prevention, screening, policy, and health services research.
Why publish in iCancer?
Open access
Accepted articles will be immediately available to readers without subscription barriers.
Launch-stage support
APCs are currently waived while the journal platform and editorial workflow are being established.